Palo Alto, Calif.-based pharma company Neumentum said today that it raised $6 million in a Series A round through the sale of convertible preferred stock. The company plans to use its newly-acquired funds to advance two non-opioid drug products designed for pain management. “People in pain – and the professionals who treat them – deserve […]
